Brooks Laboratories Ltd
NSE:BROOKS
Brooks Laboratories Ltd
NSE:BROOKS
Price:
75.55
INR
-1.44%
Market Closed
Market Cap:
₹2.2B
Relative Value
The Relative Value of one
BROOKS
stock under the Base Case scenario is
121.91
INR.
Compared to the current market price of 75.55 INR,
Brooks Laboratories Ltd
is
Undervalued by 38%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BROOKS
Relative Value
Base Case
121.91
INR
Undervaluation 38%
Multiples Across Competitors
BROOKS Competitors Multiples
Brooks Laboratories Ltd Competitors
Brooks Laboratories Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Brooks Laboratories Ltd
NSE:BROOKS
|
2.2B INR | 2.5 | 10.3 | 28.2 | 35.1 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.1T USD | 375.4 | 4 444.8 | 1 409.2 | 3 011 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
191.7B USD | 4.3 | 28.7 | 20 | 26.9 | |
| US |
|
Danaher Corp
NYSE:DHR
|
148.4B USD | 6.1 | 41.2 | 22.8 | 34.7 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
79.2T KRW | 8.4 | 29 | 29.1 | 38.8 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
36.8B CHF | 5.7 | 39.3 | 28.8 | 28.8 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
291.5B CNY | 6.6 | 19.4 | 19.7 | 19.7 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
34.7B USD | 5 | 26.6 | 19.4 | 23 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
28.2B USD | 1.7 | 20.6 | 11.6 | 17.4 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
28.1B USD | 7 | 32.3 | 23.8 | 26.5 | |
| CN |
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
164.6B HKD | 7.3 | 34.7 | 24.4 | 24.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
